Biogen's Abandonment of AD Drug No Surprise, Experts Say
More than 2 years after its controversial accelerated FDA approval, Biogen says it will halt development and commercialization of aducanumab and focus on lecanemab.
Source: medscape.com
Dave Knopman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dave Knopman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dave Knopman Today - Breaking & Trending Today
Can exercise combat dementia? Minnesota researchers aim to find out
Minnesota is a center in an urgent and growing national effort to study exercise and whether it can inhibit dementia.
Source: startribune.com